INVO Fertility, Inc. Common Stock (IVF) Stock Price

IVFStock

$0.56−99.00%52W

Market Cap$2.57M

P/E—

PEG Ratio—

Div yield—

Beta2.45

IVF Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-84.33%

Price vs S&P 500 (4W)-40.47%

VGM Score52.37

Book Value / Share (Quarterly)$7.19

P/TBV (Annual)0.30x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)102.82%

Cash Flow / Share (Quarterly)$-2.10

Price vs S&P 500 (YTD)-97.14%

Gross Margin (TTM)35.28%

Net Profit Margin (TTM)-70.18%

EPS (TTM)$-28.17

10-Day Avg Trading Volume0.13M

EPS Excl Extra (TTM)$-28.17

Revenue Growth (5Y)45.75%

EPS (Annual)$-199.21

ROI (Annual)-252.32%

Gross Margin (Annual)36.96%

Net Profit Margin (5Y Avg)-447.32%

Cash / Share (Quarterly)$1.63

Revenue Growth QoQ (YoY)16.73%

ROA (Last FY)-115.35%

Revenue Growth TTM (YoY)13.76%

EBITD / Share (TTM)$-5.79

ROE (5Y Avg)-301.08%

Operating Margin (TTM)-97.32%

Cash Flow / Share (Annual)$-14.79

P/B Ratio0.16x

P/B Ratio (Quarterly)0.21x

Net Income / Employee (Annual)$-833,000

EV / Revenue (TTM)0.08x

Net Interest Coverage (TTM)-6.41x

ROA (TTM)-23.61%

EPS Incl Extra (Annual)$-199.21

Current Ratio (Annual)0.27x

Quick Ratio (Quarterly)0.61x

3-Month Avg Trading Volume3.01M

52-Week Price Return-99.00%

Revenue / Employee (TTM)$269,000

Tangible BV / Share (Quarterly)$6.59

P/S Ratio (Annual)0.39x

Asset Turnover (Annual)0.34x

52-Week High$84.40

Operating Margin (5Y Avg)-374.89%

EPS Excl Extra (Annual)$-199.21

CapEx CAGR (5Y)-13.57%

26-Week Price Return-74.42%

Quick Ratio (Annual)0.22x

13-Week Price Return-46.38%

Total Debt / Equity (Annual)0.28x

Current Ratio (Quarterly)0.71x

Enterprise Value$567,600

Revenue / Share Growth (5Y)72.26%

Asset Turnover (TTM)0.34x

Revenue / Employee (Annual)$244,300

Inventory Turnover (Annual)19.38x

Pretax Margin (Annual)-80.20%

Cash / Share (Annual)$4.35

3-Month Return Std Dev134.59%

Gross Margin (5Y Avg)54.66%

Net Income / Employee (TTM)$-188,800

ROE (Last FY)-322.85%

Net Interest Coverage (Annual)-20.40x

EPS Basic Excl Extra (Annual)$-199.21

P/FCF (TTM)198.84x

Receivables Turnover (TTM)30.13x

Total Debt / Equity (Quarterly)0.10x

EPS Incl Extra (TTM)$-28.17

Receivables Turnover (Annual)41.42x

ROI (TTM)-40.55%

P/S Ratio (TTM)0.35x

Pretax Margin (5Y Avg)-389.91%

Revenue / Share (Annual)$58.43

Tangible BV / Share (Annual)$12.36

Price vs S&P 500 (52W)-114.54%

Year-to-Date Return-85.21%

5-Day Price Return-23.20%

EPS Normalized (Annual)$-199.21

ROA (5Y Avg)-101.60%

Net Profit Margin (Annual)-340.92%

Month-to-Date Return-38.74%

EBITD / Share (Annual)$-66.33

Operating Margin (Annual)-123.42%

LT Debt / Equity (Annual)0.10x

ROI (5Y Avg)-145.38%

LT Debt / Equity (Quarterly)0.03x

EPS Basic Excl Extra (TTM)$-28.17

P/TBV (Quarterly)0.22x

P/B Ratio (Annual)0.25x

Inventory Turnover (TTM)21.02x

Pretax Margin (TTM)-71.43%

Book Value / Share (Annual)$15.13

Price vs S&P 500 (13W)-49.07%

Beta2.45x

P/FCF (Annual)2.11x

Revenue / Share (TTM)$2.91

ROE (TTM)-47.41%

52-Week Low$0.51

vGradeB

gGradeB

mGradeF

vgmGradeC

IVF Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 14, 2026	-$5.60	-$0.60	+89.36%(+$5.00)
Q1 2026	Jun 22, 2026	-$10.00	-$3.36	+66.37%(+$6.64)

IVF Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.00

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
IVFINVO Fertility, Inc. Common Stock	B	B	F	0.4x	45.8%	35.3%	-97.3%	$0.56
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About INVO Fertility, Inc. Common Stock

INVO Fertility Inc. is a healthcare company focused on expanding access to assisted reproductive technology through its proprietary INVOcell medical device, which enables fertilization and early embryo development to occur within the patient's body. The company operates through three revenue-generating segments: clinical services (including its WFI and Atlanta-based clinics), INVOcell device manufacturing and sales, and therapeutics through its acquired subsidiary NTI. This diversified model combines direct patient care with medical device commercialization to address the growing fertility treatment market.